Boston Partners
QCOR

Boston Partners’s QUESTCOR PHARMA INC QCOR Stock Holding History

Boston Partners’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-122,593
Closed -$7.96M – 768
2014
Q1 		$7.96M Buy
+122,593
New +$7.83M 0.01% 434

Other funds holding QCOR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners's QCOR Position: Q2 2014 in Review

Boston Partners sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 122,593 shares — an estimated $7.96M sold.

Boston Partners first reported a position in QCOR in Q1 2014 and held it in 1 quarter. The position peaked at $7.96M in Q1 2014. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

  • Boston Partners reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
  • Boston Partners sold 122,593 QUESTCOR PHARMA INC shares in Q2 2014, an estimated $7.96M.
  • Boston Partners first reported a position in QUESTCOR PHARMA INC in Q1 2014 and held it in 1 quarter.
  • Boston Partners's QUESTCOR PHARMA INC position peaked at $7.96M in Q1 2014.
  • 320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Boston Partners's 13F filing for Q2 2014, filed 8 Aug 2014.